Giles CM, Huth MC, Wilson TE, Lewis HBM, Grove GEB. Three examples of a new antibody, anti-Csa, which reacts with 98% of red cell samples. Vox Sang 1965;10:405–15.10.1111/j.1423-0410.1965.tb04354.x5851803
Helgeson M, Swanson J, Polesky HF. Knops-Helgeson (Kna), a high frequency erythrocyte antigen. Transfusion 1970;10:737–8.10.1111/j.1537-2995.1970.tb00720.x4192883
Molthan L, Moulds J. A new antigen, McCa (McCoy), and its relationship to Kna (Knops). Transfusion 1978;18:566–8.10.1046/j.1537-2995.1978.18579036386.x705863
Lacey P, Laird-Fryer B, Block U, Lair J, Guilbeau L. Moulds JJ. A new high incidence blood group factor, Sla; and its hypothetical allele. (abstract).Transfusion 1980;20:632.
Daniels GL, Cartron JP, Fletcher A, et al. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver report. Vox Sang 2003;84:244–7.10.1046/j.1423-0410.2003.00282.x12670376
Moulds JM, Pierce S, Peck KB, Tulley ML, Doumbo O, Moulds JJ. KAM: a new allele in the Knops Blood Group System (abstract). Transfusion 2005;45(Suppl):27A.
Daniels G, Castilho L, Flegel WA. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Cape Town report. Vox Sang 2007;92:250–3.10.1111/j.1423-0410.2007.00887.x17348875
Moulds JM, Kassambara L, Middleton JJ. Identification of complement receptor one (CR1) polymorphisms in west Africa. Genes Immun 2000;1:325–9.10.1038/sj.gene.636367611196694
Moulds JM, Nickells MW, Moulds JJ, Brown M, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J Exp Med 1991;173:1159–63.10.1084/jem.173.5.115921188661708809
Petty AC, Green CA, Poole J, Daniels GL. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting. Transfus Med 1997;7:55–62.10.1046/j.1365-3148.1997.d01-71.x
Holme E, Fyfe A, Zoma A, Veitch J, Hunter J, Whaley K. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 1986;63:41–8.
Pascual M, Lutz HU, Steiger G, Stammler P, Schifferli JA. Release of vesicles enriched in complement receptor 1 from human erythrocytes. J Immunol 1993;151:397–404.
Daniels GL, Shaw MA, Lomas CG, Leak MR, Tippett P. The effect of In(Lu) on some high-frequency antigens. Transfusion 1986;26:171–2.10.1046/j.1537-2995.1986.26286152909.x
Pascual M, Steiger G, Sadallah S, et al. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med 1994;179:889–99.10.1084/jem.179.3.889
Danielsson C, Pascual M, Larsen B, Steiger G, Schifferli JA. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 1994;24:2725–31.10.1002/eji.1830241123
Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97:2879–85.10.1182/blood.V97.9.2879
Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.10.1111/j.1537-2995.2004.03427.x
Vik DP, Wong WW. Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. J Immunol 1993;151:6214–24.
Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986;164:50–9.10.1084/jem.164.1.50
Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998;87:176–83.10.1006/clin.1998.45299614933
Rowe JA, Plowe CV, Diallo DA, et al. Erythrocyte complement receptor 1 expression level does not correlate with HindIII restriction fragment length polymorphism in; implications for studies on malaria susceptibility. Genes Immun 2002;8:497–500.10.1038/sj.gene.636389912486610
Cockburn IA, Rowe JA. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3’ untranslated regions of the CR1 gene. Int J Immunogenet 2006;33:17–20.10.1111/j.1744-313X.2005.00552.x286902216426237
Daniels GL, Anstee DJ, Cartron JP, et al. International Society of Blood Transfusion working party on terminology for red cell surface antigens. Vox Sang 2001;80:193–6.10.1046/j.1423-0410.2001.00024.x11449960
Moulds JM, Zimmerman PA, Doumbo OK, et al. Expansion of the Knops blood group system and subdivision of Sla. Transfusion 2002;42:251–6.10.1046/j.1537-2995.2002.00002.x11896343
Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte protein and complement-receptor 1. Nature 1997;388:292–5.10.1038/408889230440
Rowe JA, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995;63:2323–6.10.1128/iai.63.6.2323-2326.19951733047768616
Da Silva RP, Hall BF, Joiner KA, Sacks DL. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol 1989;143:617–22.
Payne NR, Horwitz MA. Phagocytosis of legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med 1987;166:1377–89.10.1084/jem.166.5.137721896473316470
Noumsi GT, Tounkara A, Diallo D, Moulds JM. Knops blood group polymorphism and protection from Mycobacterium tuberculosis (abstract). Transfusion 2006;46(Suppl):19A.